Chukyoiyakuhin Co.,Ltd.TSE 4558
株式会社中京医薬品 · Pharmaceutical · FY ends Mar
Share price at FY-end
¥202
FY ending Mar 2026
Market cap at FY-end
¥2.4B
Avg. director pay
¥25.0M
Internal directors
Top 10 shareholders
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|
| 1 |
株式会社マサユキコーポレーション
|
1,625,000 |
14.94% |
¥328M |
¥8.1M |
| 2 |
山田 正行
|
334,000 |
3.07% |
¥67.5M |
¥1.7M |
| 3 |
早乙女 修司
|
289,000 |
2.66% |
¥58.4M |
¥1.4M |
| 4 |
知多信用金庫
|
200,000 |
1.83% |
¥40.4M |
¥1.0M |
| 5 |
JPモルガン証券株式会社
|
198,000 |
1.82% |
¥40.0M |
¥990,000 |
| 6 |
株式会社日本カストディ銀行
|
197,000 |
1.81% |
¥39.8M |
¥985,000 |
| 7 |
中京医薬品従業員持株会
|
161,000 |
1.48% |
¥32.5M |
¥805,000 |
| 8 |
杉浦 直幸
|
153,000 |
1.41% |
¥30.9M |
¥765,000 |
| 9 |
株式会社三菱UFJ銀行
|
150,000 |
1.37% |
¥30.3M |
¥750,000 |
| 10 |
山田 正人
|
145,000 |
1.33% |
¥29.3M |
¥725,000 |
Officers' holdings and pay
| Name | Title | Shares | Value | Pay |
|---|
| 山田 正行 |
Chairman & Representative Director |
334,000 |
¥67.5M |
— |
| 米津 秀二 |
President & Representative Director |
27,000 |
¥5.5M |
— |
| 飯田 亨 |
Director |
20,000 |
¥4.0M |
— |
| 岩崎 雷凱 |
Director |
18,000 |
¥3.6M |
— |
| 渡邊 明 |
Director |
— |
— |
— |
| 今枝 なほみ |
Director |
— |
— |
— |
| 中井 徹 |
Full-time Audit & Supervisory Board Member |
15,000 |
¥3.0M |
— |
| 吉田 和永 |
Audit & Supervisory Board Member |
— |
— |
— |
| 杉山 彰洋 |
Audit & Supervisory Board Member |
10,000 |
¥2.0M |
— |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
Per-share data by fiscal year
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|
| FY ending Mar 2026 |
¥202 |
¥7.84 |
25.8x |
¥5.0 |
11,660,000 |
| FY ending Mar 2025 |
¥206 |
¥4.24 |
48.6x |
¥5.0 |
11,660,000 |
| FY ending Mar 2024 |
¥206 |
¥-2.57 |
— |
¥5.0 |
11,660,000 |
| FY ending Mar 2023 |
¥224 |
¥1.36 |
164.7x |
¥5.0 |
11,660,000 |
| FY ending Mar 2022 |
¥269 |
¥3.16 |
85.1x |
¥5.0 |
11,660,000 |
| FY ending Mar 2021 |
¥359 |
¥10.51 |
34.2x |
¥7.0 |
11,660,000 |
| FY ending Mar 2020 |
¥674 |
¥1.19 |
566.4x |
¥5.0 |
11,660,000 |
| FY ending Mar 2019 |
¥280 |
¥3.41 |
82.1x |
¥5.0 |
11,660,000 |
| FY ending Mar 2018 |
¥293 |
¥1.40 |
209.3x |
¥5.0 |
11,660,000 |
| FY ending Mar 2017 |
¥289 |
¥5.91 |
48.9x |
¥5.0 |
11,660,000 |
Source: annual securities reports on EDINET. Values are estimates.
Methodology